Search Results

There are 27846 results for: content related to: Results of a Phase II trial of oral bexarotene (Targretin) combined with interferon alfa-2b (Intron-A) for patients with cutaneous T-cell lymphoma

  1. Bexarotene therapy for mycosis fungoides and Sézary syndrome

    British Journal of Dermatology

    Volume 160, Issue 6, June 2009, Pages: 1299–1307, R.A. Abbott, S.J. Whittaker, S.L. Morris, R. Russell-Jones, T. Hung, S.J. Bashir and J.J. Scarisbrick

    Version of Record online : 16 FEB 2009, DOI: 10.1111/j.1365-2133.2009.09037.x

  2. U.K. consensus statement on safe clinical prescribing of bexarotene for patients with cutaneous T-cell lymphoma

    British Journal of Dermatology

    Volume 168, Issue 1, January 2013, Pages: 192–200, J.J. Scarisbrick, S. Morris, R. Azurdia, T. Illidge, E. Parry, R. Graham-Brown, R. Cowan, E. Gallop-Evans, R. Wachsmuth, M. Eagle, A.S. Wierzbicki, H. Soran, S. Whittaker and E.M. Wain

    Version of Record online : 3 DEC 2012, DOI: 10.1111/bjd.12042

  3. Retinoids

    Standard Article

    Burger's Medicinal Chemistry and Drug Discovery

    Marcia I. Dawson

    Published Online : 15 SEP 2010, DOI: 10.1002/0471266949.bmc065.pub2

  4. Controversies in the management of the cutaneous T cell lymphomas

    Dermatologic Therapy

    Volume 22, Issue 5, September/October 2009, Pages: 407–417, John A. Zic

    Version of Record online : 1 SEP 2009, DOI: 10.1111/j.1529-8019.2009.01257.x

  5. The optimal use of bexarotene in cutaneous T-cell lymphoma

    British Journal of Dermatology

    Volume 157, Issue 3, September 2007, Pages: 433–440, R. Gniadecki, C. Assaf, M. Bagot, R. Dummer, M. Duvic, R. Knobler, A. Ranki, P. Schwandt and S. Whittaker

    Version of Record online : 6 JUN 2007, DOI: 10.1111/j.1365-2133.2007.07975.x

  6. You have free access to this content
    Absence of modulation of CD4+CD25high regulatory T cells in CTCL patients treated with bexarotene

    Experimental Dermatology

    Volume 19, Issue 8, August 2010, Pages: e95–e102, Anne Chantal Knol, Gaëlle Quéreux, Anabelle Brocard, Fabienne Ballanger, Amir Khammari, Jean-Michel Nguyen and Brigitte Dréno

    Version of Record online : 21 OCT 2009, DOI: 10.1111/j.1600-0625.2009.00993.x

  7. Interventions for mycosis fungoides

    Intervention Review

    The Cochrane Library

    Tobias Weberschock, Reinhard Strametz, Maria Lorenz, Christoph Röllig, Charles Bunch, Andrea Bauer and Jochen Schmitt

    Published Online : 12 SEP 2012, DOI: 10.1002/14651858.CD008946.pub2

  8. Bexarotene activates the p53/p73 pathway in human cutaneous T-cell lymphoma

    British Journal of Dermatology

    Volume 160, Issue 3, March 2009, Pages: 519–526, N. Nieto-Rementería, G. Pérez-Yarza, M.D. Boyano, A. Apraiz, R. Izu, J.L. Díaz-Pérez and A. Asumendi

    Version of Record online : 25 NOV 2008, DOI: 10.1111/j.1365-2133.2008.08931.x

  9. Retinoids: therapeutic applications and mechanisms of action in cutaneous T-cell lymphoma

    Dermatologic Therapy

    Volume 16, Issue 4, December 2003, Pages: 322–330, Chunlei Zhang and Madeleine Duvic

    Version of Record online : 24 DEC 2003, DOI: 10.1111/j.1396-0296.2003.01644.x

  10. Topical and oral bexarotene

    Dermatologic Therapy

    Volume 26, Issue 5, September/October 2013, Pages: 400–403, Courtney R. Schadt

    Version of Record online : 4 OCT 2013, DOI: 10.1111/dth.12087

  11. Minimizing adverse side-effects of oral bexarotene in cutaneous T-cell lymphoma: an expert opinion

    British Journal of Dermatology

    Volume 155, Issue 2, August 2006, Pages: 261–266, C. Assaf, M. Bagot, R. Dummer, M. Duvic, R. Gniadecki, R. Knobler, A. Ranki, P. Schwandt and S. Whittaker

    Version of Record online : 12 MAY 2006, DOI: 10.1111/j.1365-2133.2006.07329.x

  12. Omega-3 fatty acids as adjunctive treatment for bexarotene-induced hypertriglyceridaemia in patients with cutaneous T-cell lymphoma

    Clinical and Experimental Dermatology

    I. Cabello, O. Servitje, X. Corbella, I. Bardés and X. Pintó

    Version of Record online : 24 FEB 2017, DOI: 10.1111/ced.13044

  13. Phase I/II study of the oral retinoid X receptor agonist bexarotene in Japanese patients with cutaneous T-cell lymphomas

    The Journal of Dermatology

    Volume 44, Issue 2, February 2017, Pages: 135–142, Toshihisa Hamada, Makoto Sugaya, Yoshiki Tokura, Mikio Ohtsuka, Ryoji Tsuboi, Tetsuo Nagatani, Mamori Tani, Mitsuru Setoyama, Shigeto Matsushita, Kazuhiro Kawai, Kentaro Yonekura, Tsuyoshi Yoshida, Toshiaki Saida and Keiji Iwatsuki

    Version of Record online : 20 AUG 2016, DOI: 10.1111/1346-8138.13542

  14. Lack of apoptosis of Sézary cells in the circulation following oral bexarotene therapy

    British Journal of Dermatology

    Volume 152, Issue 6, June 2005, Pages: 1199–1205, S. Brennand, V.R. Sutton, J. Biagi, J.A. Trapani, D. Westerman, C.J. McCormack, J.F. Seymour, G. Kennedy and H.M. Prince

    Version of Record online : 22 JUN 2005, DOI: 10.1111/j.1365-2133.2005.06539.x

  15. Treatment of cutaneous T-cell lymphoma with retinoids

    Dermatologic Therapy

    Volume 19, Issue 5, September 2006, Pages: 264–271, Chunlei Zhang and Madeleine Duvic

    Version of Record online : 2 OCT 2006, DOI: 10.1111/j.1529-8019.2006.00083.x

  16. You have free access to this content
    Oral bexarotene in a therapy-resistant Sézary syndrome patient: observations on Sézary cell compartmentalization

    International Journal of Dermatology

    Volume 44, Issue 1, January 2005, Pages: 25–28, Rokea A. El-Azhary and Saskia A. Bouwhuis

    Version of Record online : 31 MAR 2004, DOI: 10.1111/j.1365-4632.2004.02132.x

  17. RESEARCH REPORT Bexarotene capsules and gel for previously treated patients with cutaneous T-cell lymphoma: Results of the Australian patients treated on phase II trials

    Australasian Journal of Dermatology

    Volume 42, Issue 2, May 2001, Pages: 91–97, H Miles Prince, Christopher McCormack, Gail Ryan, Christopher Baker, Harvey Rotstein, Jill Davison and Richard Yocum

    Version of Record online : 15 JAN 2002, DOI: 10.1046/j.1440-0960.2001.00488.x

  18. Bexarotene and narrowband ultraviolet B phototherapy combination treatment for mycosis fungoides

    Photodermatology, Photoimmunology & Photomedicine

    Volume 23, Issue 6, December 2007, Pages: 255–257, Michele L. Lokitz and Henry K. Wong

    Version of Record online : 1 NOV 2007, DOI: 10.1111/j.1600-0781.2007.00315.x

  19. You have free access to this content
    About the cutaneous targets of bexarotene in CTCL patients

    Experimental Dermatology

    Volume 19, Issue 8, August 2010, Pages: e299–e301, Anne Chantal Knol, Gaëlle Quéreux, Anabelle Brocard, Fabienne Ballanger, Amir Khammari, Jean-Michel Nguyen and Brigitte Dréno

    Version of Record online : 21 OCT 2009, DOI: 10.1111/j.1600-0625.2009.00995.x

  20. You have free access to this content
    Evolving Insights in the Pathogenesis and Therapy of Cutaneous T-cell lymphoma (Mycosis Fungoides and Sezary Syndrome)

    British Journal of Haematology

    Volume 155, Issue 2, October 2011, Pages: 150–166, Henry K. Wong, Anjali Mishra, Timothy Hake and Pierluigi Porcu

    Version of Record online : 25 AUG 2011, DOI: 10.1111/j.1365-2141.2011.08852.x